点击次数：

论文类型：期刊论文

发表时间：2011-09-01

发表刊物：CURRENT MEDICINAL CHEMISTRY

收录刊物：Scopus、SCIE、PubMed

卷号：18

期号：26

页面范围：4019-4028

ISSN号：0929-8673

关键字：HCV NS5B; benzothiadiazine scaffold-based inhibitors; 3D-QSAR; CoMFA; CoMSIA; molecular docking; molecular dynamics

摘要：Hepatitis C virus (HCV) infection is a significant world health threat with frequently ineffective problem existed in the present treatment, thus representing a major unmet medical need. The nonstructural viral protein 5B (NS5B), one of the best-studied polymerase, has emerged as an attractive target for the development of novel therapeutics against hepatitis C virus. In this work, both ligand-and receptor-based three-dimensional quantitative structure-activity relationship (3D-QSAR) studies were carried out using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques on 360 benzothiadiazine scaffold-based derivatives as HCV GT-1b NS5B polymerase allosteric inhibitors. The resultant optimum 3D-QSAR model exhibited R(cv)(2) of 0.54, R(ncv)(2) of 0.72 and the predictive ability was validated by using an independent test set of 90 compounds which gave R(pred)(2) value of 0.64. In addition, docking analysis and molecular dynamics simulation (MD) were also applied to elucidate the probable binding modes of these inhibitors at the allosteric site of the enzyme. Interpretation of the 3D contour maps in context of the topology of the allosteric binding site of NS5B provided insight into NS5B-inhibitor interactions. The information obtained from this work can be utilized to accurately predict the binding affinity of related analogues and also facilitate the future rational design of novel inhibitors with improved activity.